COMMUNIQUÉS West-GlobeNewswire

Cullinan Therapeutics Shares New Clinical Data Across Its Portfolio of T Cell Engager Programs Targeting CD19 and BCMA in Autoimmune Diseases
10/06/2026
CLN-978 (CD19 TCE) EULAR data demonstrated potential for immune reset, including remissions, in both systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) CLN-978 data from the first RA multi-dose regimen [...]
BMGL to Effect Reverse Share Split on June 22, 2026
10/06/2026
SINGAPORE, June 10, 2026 (GLOBE NEWSWIRE) -- Basel Medical Group Ltd (Nasdaq: BMGL) (the “Company”), a medical clinic operator in Singapore, today announced that the Company’s board of directors has approved the [...]
Polyrizon Receives Notice of European Patent Publication for Innovative Mucoadhesive Nasal Drug Delivery Technology
10/06/2026
Raanana, Israel, June 10, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a development-stage biotech company specializing in the development of innovative intranasal hydrogels, [...]
Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc.
10/06/2026
Lisata stockholders to receive $4.00 per share in cash at closing, plus one non-tradeable contingent value right, which represents the contractual right to receive two contingent cash payments of up to an aggregate of $ [...]
Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio
10/06/2026
Additional Orange Book Listed Patent Secured and Composition of Matter Patent is Eligible for 5-Year Extension CAMBRIDGE, Mass., June 10, 2026 (GLOBE NEWSWIRE) -- Akebia Therapeutics ® , Inc. (Nasdaq: AKBA), a [...]
CONVOCATION A UNE ASSEMBLEE GENERALE EXTRAORDINAIRE D’IBA SA
10/06/2026
- - LUNDI 29 JUIN 2026 A 11H00 - - Cher Actionnaire, Le quorum requis pour la délibération et le vote sur les sujets à l'ordre du jour de l’assemblée générale extraordinaire des actionnaires de la Société qui était [...]
Ethyreal Bio Emerges from Stealth with $101 Million in Financing to Advance ETHY-001, a Potentially Best-in-Class Anti-TSHR Antibody for Thyroid Eye Disease and Graves’ Disease
10/06/2026
– ETHY-001 targets the causal pathogenic mechanism underlying both conditions – – Patient-friendly subcutaneous administration with half-life extension for infrequent dosing – – First-in-human clinical trial expected to [...]
Data Published in Interventional Pain Medicine Indicates Participants Who Received SPRINT PNS as Prescribed Were Three Times More Likely to Achieve Meaningful Pain Relief
10/06/2026
CLEVELAND, June 10, 2026 (GLOBE NEWSWIRE) -- SPR ® announced the publication of “Observations from the RESET Clinical Trial: A Post-Hoc Per Protocol Analysis of Clinical Outcomes with Percutaneous 60-Day Medial Branch [...]
Autonomix Medical Announces Release of New CEO Corner Segment Highlighting Global Scientific and Clinical Recognition of Platform Technology
10/06/2026
Access the segment here THE WOODLANDS, TX, June 10, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing precision nerve- [...]
Beacon Biosignals Unifies Brands, Bringing CleveMed and SleepView® Under the Beacon Name
10/06/2026
Beacon expands home sleep diagnostics with EEG-enabled testing through Waveband, building on CleveMed's established clinical and operational foundation. BOSTON, June 10, 2026 (GLOBE NEWSWIRE) -- Beacon Biosignals today [...]
Aclarion to Present at the Planet MicroCap Las Vegas Powered by MicroCapClub
10/06/2026
BROOMFIELD, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Aclarion, Inc ., (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a commercial-stage healthcare technology company leveraging biomarkers and proprietary augmented [...]
Prenetics Announces Record Q1 2026 Results with IM8 Revenue Reaching a Record ~$16.7 Million in May, Implying ~$200 Million in Annualized Recurring Revenue
10/06/2026
Q1 2026 revenue of $36.0 million with IM8 revenue of $33.8 million , up 23.1% from IM8 revenue of $27.4 million in Q4 2025 and nearly 6x year-over-year from IM8 revenue of $5.7 million in Q1 2025 Raises full-year 2026 [...]
Pioneering evidence shows how entrepreneurship model can reduce extreme poverty among refugees
10/06/2026
New studies show DREAMS program boosts incomes, savings, and resilience in refugee communities across East Africa The IKEA Foundation has committed $7.4m to fund the next stage of DREAMS in Ethiopia while the Conrad N. [...]
Profusa Issues Letter to Shareholders Encouraging Shareholders to Vote FOR All Proposals at June 23, 2026 Annual Meeting
10/06/2026
BERKELEY, CA, June 10, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a leading digital health company pioneering next-generation biosensing technologies, today issued the following [...]
MAIA Biotechnology Activates and Opens Enrollment at Second U.S. Clinical Site for International Phase 2 THIO-101 Expansion Trial
10/06/2026
Additional data from MAIA’s THIO-101 expansion may further support an accelerated approval filing with the FDA Potential breakthrough therapy holds substantial commercial opportunity in a projected $70 billion global [...]
Physician Pay and Productivity Are Moving in Opposite Directions, MGMA Report Finds
10/06/2026
New benchmarks show compensation rising across all specialties in 2025 even as patient visits fell in all 23 core specialties and standard productivity measures declined in most — a disconnect driven by a worsening [...]
genXtraits, Mendel Biotechnology and AgGene Announce Collaboration to Develop Stress-Resilient Canola Traits
10/06/2026
SAN FRANCISCO, June 10, 2026 (GLOBE NEWSWIRE) -- San Francisco Bay Area based biotechnology firms, genXtraits Inc. (genXtraits) and Mendel Biotechnology, Inc. (Mendel), have announced a joint collaboration with AgGene [...]
Vivos Therapeutics Announces Key Collaboration Agreement with Multi-Location Florida Cardiology Group to Extend Much Needed Sleep Apnea and Insomnia Diagnosis and Treatment to Cardiovascular Patients
10/06/2026
LITTLETON, Colo., June 10, 2026 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. ("Vivos" or the "Company") (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing- [...]
Senseonics and Welldoc Partner to Develop Next-Generation App for Eversense® 365
10/06/2026
The new app will offer an enhanced user experience and exciting new features, including improved integration popular digital health tools The app is expected to launch in the second half of 2026 GERMANTOWN, Md. and [...]

Pages